Literature DB >> 9420585

The opinions and experiences of family physicians regarding direct-to-consumer advertising.

M S Lipsky1, C A Taylor.   

Abstract

BACKGROUND: The use of direct-to-consumer advertising (DTCA) by pharmaceutical companies is increasing. Our study examines the opinions and experiences of family physicians concerning DTCA.
METHODS: A survey instrument designed to elicit the opinions, experiences, and perceptions of family physicians about DTCA was sent to a 2% (N = 880) systematic sampling of active physician members of the American Academy of Family Physicians. Descriptive statistics were used to analyze responses with t tests and chi 2 tests for independence used to examine subgroup response differences.
RESULTS: Four hundred fifty-four (52%) physicians responded to the survey. Most physicians (95%) had encountered DTCA personally, and had been approached by an average of 7 patients over the previous 6 months with requests for specific prescription drugs. Prescription antihistamines and antihypertensive drugs were the most commonly requested. Overall, 80% of the physician respondents believed that print DTCA was not a good idea, while 84% expressed negative feelings about television and radio advertising. Both groups cited "misleading biased view" and "increased costs" as the most common disadvantages. Some reported benefits included "better informed patients" and "promoting physician-patient communication."
CONCLUSIONS: Overall, the study group physicians had negative feelings about DTCA in both print and electronic media. Studies directly examining patient perspectives, as well as cost benefits, are necessary to test the validity of the physicians' perceptions about DTCA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9420585

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  15 in total

1.  Direct-to-consumer advertising.

Authors:  Marc Lacroix
Journal:  CMAJ       Date:  2004-03-02       Impact factor: 8.262

2.  Pharmacy students' knowledge, attitudes, and evaluation of direct-to-consumer advertising.

Authors:  Rupali K Naik; Matthew E Borrego; Gireesh V Gupchup; Melanie Dodd; Mike R Sather
Journal:  Am J Pharm Educ       Date:  2007-10-15       Impact factor: 2.047

3.  Seniors' perceptions of prescription drug advertisements: a pilot study of the potential impact on informed decision making.

Authors:  Jerry L Grenard; Visith Uy; José A Pagán; Dominick L Frosch
Journal:  Patient Educ Couns       Date:  2010-11-01

Review 4.  Cancer-related direct-to-consumer advertising: a critical review.

Authors:  Emily Z Kontos; K Viswanath
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

5.  Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

Authors:  Jessica T DeFrank; Nancy D Berkman; Leila Kahwati; Katherine Cullen; Kathryn J Aikin; Helen W Sullivan
Journal:  Health Commun       Date:  2019-04-11

6.  Potential spillover educational effects of cancer-related direct-to-consumer advertising on cancer patients' increased information seeking behaviors: results from a cohort study.

Authors:  Andy S L Tan
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

7.  Learning from marketing: Rapid development of medication messages that engage patients.

Authors:  Veronica Yank; Erika Tribett; Lydia Green; Jasmine Pettis
Journal:  Patient Educ Couns       Date:  2015-03-14

8.  Factors affecting physicians' responses to patients' requests for antidepressants: focus group study.

Authors:  Aleksey Tentler; Jordan Silberman; Debora A Paterniti; Richard L Kravitz; Ronald M Epstein
Journal:  J Gen Intern Med       Date:  2007-11-07       Impact factor: 5.128

9.  Ethical and epistemic issues in direct-to-consumer drug advertising: where is patient agency?

Authors:  Catherine A Womack
Journal:  Med Health Care Philos       Date:  2013-05

10.  The effect of direct-to-consumer advertising on prescription drug use by older adults.

Authors:  Balaji Datti; Mary W Carter
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.